$2 million gene therapy cures require a financing model - Summary - MDSpire

$2 million gene therapy cures require a financing model

  • By

  • William V. Padula

  • June 8, 2026

  • 0 min

Share

Objective:

To address the financing challenges associated with high-cost gene therapies.

Key Findings:
  • Gene therapies can cure diseases with a single treatment but often cost $2 million or more.
  • Current healthcare financing models are not designed to accommodate large upfront costs for curative therapies.
  • Existing programs may improve access marginally but do not fundamentally change financing challenges.
Interpretation:

Limitations:
  • Current payment systems are fragmented and based on annual budgets.
Conclusion:

Original Source(s)

$2 million gene therapy cures require a financing model

  • by William V. Padula

  • June 8, 2026

Related Content

The appearance of “faggot Auer rods” in blasts of non-M3 acute myeloid leukemia

Tagraxofusp in adult blastic plasmacytoid dendritic cell neoplasm: clinical trials and real-world outcomes: a systematic review

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis